Format

Send to

Choose Destination
Microbiome. 2016 Sep 17;4(1):50. doi: 10.1186/s40168-016-0195-9.

Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.

Author information

1
Children's Hospital, New Orleans, LA, USA.
2
Louisiana State University Health Sciences Center, New Orleans, LA, USA.
3
Xavier University of Louisiana, New Orleans, LA, USA.
4
University at Buffalo, Buffalo, NY, USA.
5
Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.
6
Children's Hospital, New Orleans, LA, USA. davile@lsuhsc.edu.
7
Louisiana State University Health Sciences Center, New Orleans, LA, USA. davile@lsuhsc.edu.

Abstract

BACKGROUND:

End-stage renal disease (ESRD) is associated with uremia and increased systemic inflammation. Alteration of the intestinal microbiota may facilitate translocation of endotoxins into the systemic circulation leading to inflammation. We hypothesized that children with ESRD have an altered intestinal microbiota and increased serum levels of bacterially derived uremic toxins.

METHODS:

Four groups of subjects were recruited: peritoneal dialysis (PD), hemodialysis (HD), post-kidney transplant and healthy controls. Stool bacterial composition was assessed by pyrosequencing analysis of 16S rRNA genes. Serum levels of C-reactive protein (CRP), D-lactate, p-cresyl sulfate and indoxyl sulfate were measured.

RESULTS:

Compared to controls, the relative abundance of Firmicutes (P = 0.0228) and Actinobacteria (P = 0.0040) was decreased in PD patients. The relative abundance of Bacteroidetes was increased in HD patients (P = 0.0462). Compared to HD patients the relative abundance of Proteobacteria (P = 0.0233) was increased in PD patients. At the family level, Enterobacteriaceae was significantly increased in PD patients (P = 0.0020) compared to controls; whereas, Bifidobacteria showed a significant decrease in PD and transplant patients (P = 0.0020) compared to control. Alpha diversity was decreased in PD patients and kidney transplant using both phylogenetic and non-phylogenetic diversity measures (P = 0.0031 and 0.0003, respectively), while beta diversity showed significant separation (R statistic = 0.2656, P = 0.010) between PD patients and controls. ESRD patients had increased serum levels of p-cresyl sulfate and indoxyl sulfate (P < 0.0001 and P < 0.0001, respectively). The data suggests that no significant correlation exists between the alpha diversity of the intestinal microbiota and CRP, D-lactate, or uremic toxins. Oral iron supplementation results in expansion of the phylum Proteobacteria.

CONCLUSIONS:

Children with ESRD have altered intestinal microbiota and increased bacterially derived serum uremic toxins.

KEYWORDS:

Children; End-stage renal disease; Inflammation; Intestinal microbiota; Pyrosequencing; Uremic toxins

PMID:
27640125
PMCID:
PMC5027112
DOI:
10.1186/s40168-016-0195-9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center